← All sarcoma trials
Recruiting nowN/AAges 18 Years to 25 Years

Digital Art Therapy for Young Cancer Survivors

Sponsor: UNC Lineberger Comprehensive Cancer Center · NCT06789666 on ClinicalTrials.gov ↗

Conditions studied

CancerPediatric CancerPediatric MalignanciesPediatric Sarcoma of Soft TissueAdolescent and Young Adult With Brain Cancer

What it tests

  • ARTCan Appbehavioral

Where it's running1 site

  • Lineberger Comprehensive Cancer Center

    Chapel Hill, North Carolina 27599

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

* Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
* Subject is willing and able to comply with study procedures based on the judgment of the investigator.
* Age 18-25 years at the time of consent.
* Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
* Reliable internet connection and access to a computer, smartphone, or iPad to support application and virtual study visits.
* Answers "yes" to the question "Do you experience mood issues (yes or no)?".

Exclusion Criteria:

* All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.
* Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).
* Subjects who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).
* Subjects unable to provide consent.
* Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.

Updated 2025-09-16 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.